William O. Cooper, MD, MPH, is the Cornelius Vanderbilt Professor of Pediatrics and Health Policy, Associate Dean for Faculty Affairs, and Director of Vanderbilt’s Center for Patient and Professional Advocacy.
Dr. Cooper is an internationally recognized expert in medication safety in children. The results of his research, published in journals including The New England Journal of Medicine and JAMA, have led to changes in policy for prescription drugs at the US Food and Drug Administration, Health Canada, and the European Union and have influenced prescribing practices for multiple specialties, including pediatricians, obstetricians, and psychiatrists.
He has served as a member of the Food and Drug Administration’s Drug Safety and Risk Management Advisory Committee and recently provided testimony to the US Senate Committee on Health, Education, Labors, and Pensions on the use of psychotropic medications in children.
- Bobo WV, Cooper WO, Stein CM, Olfson M, Graham D, Daugherty J, Fuchs DC, Ray WA. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA psychiatry. 2013 Oct;70(10). 1067-75. PMID: 23965896 [PubMed].